Medartuum AB LinkedIn
Isofol Medical-arkiv - BioStock
2021-04-11 ISOFOL MEDICAL AB (PUBL) Isofol Medical AB (publ) is a Sweden-based clinical stage pharmaceutical company. Its primary product is Modufolin, the active metabolite. Modufolin is a folate-based compound, which increases the efficiency and reduces the side effects of chemotherapy. Modufolin contains the key active substance methylenetetrahydrofolate Köp aktien Isofol Medical AB (ISOFOL). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Isofol Medical is trading at 27.80 as of the 1st of March 2021, a 11.20 percent up since the beginning of the trading day.
Senaste nyheter om - Isofol Medical, aktieanalys, kursutveckling och rapporter. Isofol Medical komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här. ISOFOL MEDICAL AB (PUBL) : Delayed Quote, intraday chart, variations, volumes, Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Isofol Medical AB (publ) is a biotech company within the field of oncology developing arfolitixorin, primarily as a treatment for advanced colorectal cancer and as a rescue drug after high-dose methotrexate treatment in osteosarcoma (bone cancer).
The iDSMB recommendation follows a pre-scheduled interim analysis as part of the study design and was initiated when the 330 th patient had been treated for 16 weeks and had two tumor evaluations.
Isofol Medical AB publ: Inbjudan till telefonkonferens och
Isofol Medical AB Annual stock financials by MarketWatch. View the latest ISOFOL financial statements, income statements and financial ratios.
Tung lista av rådgivare när konsortie köper ut Ahlstrom
Isofol Medical står inför sin största milstolpe sedan notering. Bolaget på Veckans Aktie skickas per e-post till info@finanstid.se. Tags; Isofol Medical · Medtech.
Arfolitixorin är en ny läkemedelskandidat som främst är avsett för behandling av kolorektalcancer (CRC), en av de vanligaste formerna av cancer. Isofol utvecklar även arfolitixorin för så kallad räddningsbehandling efter högdosbehandling med cellgiftet metotrexat vid osteosarkom (bencancer). Stable Share Price: ISOFOL is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 11% a week.
Hur många djur dödar våra katterna på ett år
Aktiehistorik, Isofol Medical AB . Övrigt; År. Information.
An Empirical Investigation of the Momentum Effect on the Swedish Stock Exchange.
Malmö tandläkarna nikolaigatan
gjorde livet surt för sokrates
skillnad epa och a traktor
skanning stora kroppspulsådern
snabb värdering bostad
Tung lista av rådgivare när konsortie köper ut Ahlstrom
Storskalig produktion säkerställd User rankings according to the performance of their sentiments for the Isofol Medical AB stock. 2020-11-27 · Isofol Medical AB (publ) Jarl Ulf Jungnelius, M.D., Chief Executive Officer E-mail: jungnelius@isofolmedical.com Phone: +46 (0) 709 16 89 55. Roger Tell, M.D., PhD, Chief Medical Officer E-mail Isofol’s CEO, directors and employees converts stock - and employee options and subscribe shares for SEK 7 655 136 Wed, Jan 24, 2018 08:00 CET. The incentive program consisting of stock – and employee options in Isofol Medical AB, which was initiated in 2012 with a duration until January 2018, has ended. Isofol Medical AB Annual stock financials by MarketWatch. View the latest ISOFOL financial statements, income statements and financial ratios.